According to Fisher & Paykel Healthcare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.9. At the end of 2024 the company had a P/S ratio of 8.51.
Year | P/S ratio | Change |
---|---|---|
2024 | 8.51 | -13.84% |
2023 | 9.88 | 15.51% |
2022 | 8.56 | -9.91% |
2021 | 9.50 | -30.68% |
2020 | 13.7 |